celldex

Biotechnology · Health Care
Sponsors visas
12Open roles6 posted in 30 days+3 this week
$229kMedian advertised pay$131k – $245k+7% vs market
23 daysTime to fillmedian of 14 closed rolesmarket: 31 days
Lately:+3 roles posted this week7 news stories in 90 daysFollow changes →

Facts

as of Nov 16, 2026

About About Us Management Board of Directors Scientific Advisory Board Contact Us Celldex is pioneering new horizons in immunology to deliver life-changing therapies.

It is hiring: 12 open roles, 6 of them posted in the last 30 days.

Legal name
Celldex Therapeutics, Inc.
Founded
2017
Employees
1001-5000estimated range
Open roles
12 in 6 citiesAlion job postings
Register numbers
NAME celldex therapeutics inc
Website
celldex.com

As of Nov 16, 2026, Alion lists 12 open roles at celldex. It was founded in 2017. The median pay stated in its open roles is $229k, across 10 postings that state pay.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Legal entity active
Celldex Therapeutics, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Hiring at full speed: most open roles are fresh.

Biotech is the largest family, 23 of open roles.

6Posted in 30 days50% of open roles are fresh
8%Remote roles1 of 12
6Hiring offices
Can they hire you from United States?by your location
Likely
23 open roles are in your country: you apply locally, no move needed.
United States23On site
Remote, from elsewhere1Rare
No posting offers visa sponsorship. Remote roles: 1.
Time to fillmedian days to close a role
celldex23 days
Market, same roles31 days
Alion signals0-100
Demand9
Pay40
Your chance39
How badly they need people, whether they pay, how realistic getting in is.
Open roles over time−100%
Sep 21This week
Open roles a week: 18 then, 0 now
Where the openings areshare of open roles · trend
Biotech23▲
Operations19▼
Finance15▼
HR12
Industrial Engineering12▼
Management8▲
Newest roles
Senior Manager, Field Medical Science Liaison, Mid Atlantic (NJ/Phil)
$134k – $173k per year · In office · 3+ years exp · PhD · Philadelphia
Executive Director, Managed Markets - National and Key Accounts (Remote)
$234k – $303k per year · Remote (United States) · 15+ years exp · Bachelor's Degree · United States
Senior Director, Commercial Learning and Development and Onboarding (Remote)
$203k – $264k per year · Remote (United States) · 10+ years exp · United States
Senior Medical Science Liaison _ North Central
$134k – $213k per year · In office · PhD · Chicago
Degree asked
Bachelor's Degree 50%Doctoral Degree (PhD) 38%Associate's Degree 13%
Experience asked: 9.3 years on average, in 10 postings. 8 postings state a degree.
Benefits named in postingsshare of open roles
Equity12100%
Professional development867%
Home office18%
Contract type
Contract 1
Visa sponsorship: none statedRelocation: none stated
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family

What its postings pay, by level.

$229kMedianmarket estimate $215k
$131k – $245kTypical rangeUSD a year
$401kHighest paying roleVice President, Pharmacovigilance & Risk Management
Pay by levelmiddle half of stated pay, median marked · dashed: market median $215k
Senior3$213k$131k – $213k
Head+5$264k$229k – $349k
$0$100k$200k$300k$400k
Source: the pay stated in the company's postings, normalised to USD a year

Named in the work visa registers of United States.

United StatesUS 2 #4,273 of 8,998 sponsors
2H-1B filings in 12 months
$128kMedian offered salary
12Open roles in United States
Who they sponsor
Other managers1
Chemists1
The salary offered for each occupationVisa pass · 90 credits

In the register as Celldex Therapeutics, Hampton, NJ

Other sponsors in the same field
US Department of Labor · latest filing Jan 6, 2026

Footprint

Hiring in 6 cities in 1 country.

6Cities
1Countries
HamptonBusiest site
Loading the map
SiteTypeOpen rolesHires most forEngineering
Hampton United StatesCorporate office4Finance, Operations, Science & Research25%
New Haven United StatesNot classified2Finance, Biotech0%
Fall River United StatesNot classified1Industrial Engineering0%
Philadelphia United StatesNot classified1Biotech0%
Chicago United StatesNot classified1Biotech0%
Seattle United StatesNot classified1Biotech0%
Source: office addresses in postings and company registers

Ranked #3 by open roles among its 11 closest peers.

#CompanyHQOpen rolesSize
1Mesa LabsLakewood, United States28501-1000
2ClearviewNew York, United States1811-50
3celldexNew Haven, United States121001-5000
4AvaloTxChesterbrook, United States12
5OneOmeMinneapolis, United States-5000+
6enginexyzCambridge, United States-
7SenseonicsGermantown, United States-51-200
8Vivifi MedicalHouston, United States-11-50
Source: Alion's similar-companies engine (industry segments, technologies, headquarters country, size)

Technologies named in job postings at celldex over the last 12 months, by layer, with the share of postings for each.

14Technologies in use
6Postings analysed
78/100Stack modernityAI adopter
LanguagesPythonSQL
DatabasesSnowflake
Cloud & platformsAzureDatabricksGCP
AI & MLLLM
Sign in to see how your skills match this stackSign In
Full celldex tech stack14 technologies · by team · pay by technology · changes · similar stacks
Source: the technologies named in the company's postings and on its site

Milestones

2017
Founded
Each milestone is dated by its source: registers, filings, the press

Newsroom

Sep 242026
Press release · The Globe and Mail
Detailed price information for Celldex Therapeutics (CLDX-Q) from The Globe and Mail including charting and trades.
Sep 242026
Press release · The Globe and Mail
Detailed price information for Celldex Therapeutics (CLDX-Q) from The Globe and Mail including charting and trades.
Sep 232026
News · YahooFinance
When biopharmaceutical companies advance platform technologies targeting complex immunological pathways, market participants must weigh clinical efficacy against the heavy capita…
Sep 222026
News · YahooFinance
Celldex Therapeutics (NASDAQ:CLDX) reported positive top-line results from its two Phase III EMBARQ-CSU studies of barzolvolimab in adults with chronic spontaneous urticaria, or…
Sep 222026
News · markets.businessinsider.com
Best-in-disease results showed rapid, profound, sustained efficacy, supporting barzolvolimab's potential to be a transformational therapy in CSUEM...
Sources: the outlets named on each headline, each story once